echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > Am J Med: The efficacy of dotinurad VS. benzbromarone in hyperuricemia patients with or without gout

    Am J Med: The efficacy of dotinurad VS. benzbromarone in hyperuricemia patients with or without gout

    • Last Update: 2021-03-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Hyperuricemia is a causative factor in urate deposition diseases such as urolithiasis and gouty arthritis.


    In order to further compare the efficacy and safety of dotinurad and benzbromarone, the researchers conducted a 14-week randomized, multicenter, double-blind phase 3 study.


    The patients were randomly divided into groups (dotinurad: 102, benzbromarone: 99) and received dotinurad 2 mg or benzbromarone 50 mg, once a day for 14 weeks.


     

    The results showed that from baseline to the last visit, the average percentage changes in serum uric acid levels in the dotinurad group and benzbromarone group were 45.


    In summary, the results of this study show that in Japanese patients with hyperuricemia, whether or not they have gout, dotinurad 2 mg is non-inferior to benzbromarone 50 mg in reducing serum uric acid.


     

    Original source:

     

    Julio Núñez, Pau Llàcer, et al.


    ncbi.
    nlm.
    nih.
    gov/31980978/" target="_blank" rel="noopener">CA125-Guided Diuretic Treatment Versus Usual Care in Patients With Acute Heart Failure and Renal Dysfunction in this message
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.